During a pilot study, the glycoprotein myocilin, which is a phenotypic marker of TMCs and is involved in the pathogenesis of glaucoma, was observed not to accumulate in whole-cell lysates of TMCs stimulated with dexa and epox, the most potent and selective proteasome inhibitor. Here, MYOC is linked to glaucoma.